In today's world, Oxitropium bromide is a topic that has gained great relevance in different areas. Whether in politics, science, technology or culture, Oxitropium bromide has captured the attention of millions of people around the world. Its impact has been so significant that it has generated debates and reflections in contemporary society. In this article, we will explore the phenomenon of Oxitropium bromide in depth, analyzing its many facets and its influence on everyday life. From its origins to its present, we will take a tour of Oxitropium bromide to understand its importance today and its projection in the future.
Clinical data | |
---|---|
Trade names | Oxivent, Tersigan, Tersigat, Ventilat |
Other names | N-Ethylscopolammonium bromide; Ba 253; Ba 253BR-L; Ba 253Br; Hyoscine ethobromide; N-Ethylnorscopolamine methyl bromide; Scopolamine ethobromide |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.045.543 |
Chemical and physical data | |
Formula | C19H26BrNO4 |
Molar mass | 412.324 g·mol−1 |
3D model (JSmol) | |
| |
|
Oxitropium bromide (trade names Oxivent, Tersigan) is an anticholinergic used as a bronchodilator for the treatment of asthma and chronic obstructive pulmonary disease.
It was patented in 1966 and approved for medical use in 1983.